Cart
sales@molnova.com
(-)-TRANS-MYRTANOL
CAS No. 53369-17-8
(-)-TRANS-MYRTANOL( —— )
Catalog No. M21288 CAS No. 53369-17-8
(-)-TRANS-MYRTANOL exhibited potent antimicrobial activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 185 | Get Quote |
|
| 5MG | 93 | Get Quote |
|
| 10MG | 141 | Get Quote |
|
| 25MG | 234 | Get Quote |
|
| 50MG | 338 | Get Quote |
|
| 100MG | 503 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(-)-TRANS-MYRTANOL
-
NoteResearch use only, not for human use.
-
Brief Description(-)-TRANS-MYRTANOL exhibited potent antimicrobial activities.
-
Description(-)-TRANS-MYRTANOL exhibited potent antimicrobial activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53369-17-8
-
Formula Weight154.25
-
Molecular FormulaC10H18O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C)[C@@H]2[C@@H](CO)CC[C@H]1C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yang J Y Lee H W Lee H S . Growth inhibitory activities of myrtanol and structural analogues fromThymus toseviiagainst intestinal bacteria[J]. Food Science & Biotechnology 2015 24(1):169-174.
molnova catalog
related products
-
Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
-
20(21)-Dehydrolucide...
20(21)-Dehydrolucidenic acid D
-
(5R)-7-(4-Hydroxy-3-...
Antiviral agent 64 (Compound 12) is a diarylheptanoid that can be isolated from Alpinia officinarum. Antiviral agent 64 exhibits cytotoxicity in human neuroblastoma cell IMR-32 with an IC50 of 0.23 μM. Antiviral agent 64 exhibits antiviral efficacy, that inhibits RSV, poliovirus, measles virus, HSV-1, and influenza virus H1N1, with EC50 of 13.3, 3.7, 6.3, 5.7, and <10 μg/mL, respectively.
